Uploaded September 2025 | Updated September 2026, 1 week ago
Dr. David Beversdorf discusses the impact of ARI's early-stage biomedical research grants. Thank you to ARI donors whose generosity carries our work forward.
Visit autism.org/donate-giving to give today.
Dr. Beversdorf graduated from Indiana University and completed Neurology residency at Dartmouth. After his fellowship in Behavioral Neurology at University of Florida, he joined the Ohio State University faculty. He has published on memory disorders, autism, cognitive neuroscience, fMRI, neurpsychopharmacology and drug addiction. He joined the University of Missouri (Radiology, Neurology, Psychology and the Thompson Center) to focus on autism, with particular interest in pharmacofMRI as a potential treatment marker, and gene/stress interactions in autism.
Dr. David Beversdorf discusses the impact of ARI's early-stage biomedical research grants. Thank you to ARI donors whose generosity carries our work forward.
Visit autism.org/donate-giving to give today.
Dr. Beversdorf graduated from Indiana University and completed Neurology residency at Dartmouth. After his fellowship in Behavioral Neurology at University of Florida, he joined the Ohio State University faculty. He has published on memory disorders, autism, cognitive neuroscience, fMRI, neurpsychopharmacology and drug addiction. He joined the University of Missouri (Radiology, Neurology, Psychology and the Thompson Center) to focus on autism, with particular interest in pharmacofMRI as a potential treatment marker, and gene/stress interactions in autism.
